Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cognate Bioservices, Inc. Insider Profile
4 Followers
Cognate Bioservices, Inc., Ten Percent Owner at Northwest Biotherapeutics, holds 18.46M shares in Northwest Biotherapeutics (Ticker: NWBO). Most recently, Cognate Bioservices, Inc. Sold 1,768,092 shares of Northwest Biotherapeutics on Jul 02, 2015 for an estimated value of 7.32M.
Cognate Bioservices, Inc. Northwest Biotherapeutics (NWBO)Ten Percent Owner
Northwest Biotherapeutics (NWBO)
Ten Percent Owner
Ranked #5,358 out of 40,785 Corporate Insiders
Profitable Transactions
2 out of 7 Profitable Transactions
Average Return
+16.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Cognate Bioservices, Inc. does not currently own shares as a corporate insider.
A breakdown of Cognate Bioservices, Inc.'s holdings
Insider Roles
Ten Percent Owner
Roles that Cognate Bioservices, Inc. holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jul 02, 2015 - Jul 02, 2016
Return:+93.90%
The most profitable trade made by Cognate Bioservices, Inc.
Cognate Bioservices, Inc.'s Trading History
List of latest transactions for each holding click on a transaction to see Cognate Bioservices, Inc.'s performance on stock
You May Also Like
Cognate Bioservices, Inc. insider profile FAQ
What is the percentage of profitable transactions made by Cognate Bioservices, Inc.?
The percentage of profitable transactions made by Cognate Bioservices, Inc. is 29%.
What is the average return per transaction made by Cognate Bioservices, Inc.?
The average return per transaction made by Cognate Bioservices, Inc. is 16.70%.
What stocks does Cognate Bioservices, Inc. hold?
Cognate Bioservices, Inc. holds: NWBO stocks.
What was Cognate Bioservices, Inc.’s latest transaction?
Cognate Bioservices, Inc. latest transaction was an Informative Sell of 7.32M.
What was Cognate Bioservices, Inc.'s most profitable transaction?
Cognate Bioservices, Inc.’s most profitable transaction was an Informative Sell of NWBO stock on July 2, 2015. The return on the trade was 93.90%.
What is Cognate Bioservices, Inc.'s role in Northwest Biotherapeutics?
Cognate Bioservices, Inc.'s role in Northwest Biotherapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.